(R)-CSN5i-3

CAS No. 2863607-74-1

(R)-CSN5i-3( —— )

Catalog No. M33089 CAS No. 2863607-74-1

(R)-CSN5i-3 is CSN5i-3 of the R configuration.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 353 In Stock
10MG 491 In Stock
25MG 845 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (R)-CSN5i-3
  • Note
    Research use only, not for human use.
  • Brief Description
    (R)-CSN5i-3 is CSN5i-3 of the R configuration.
  • Description
    (R)-CSN5i-3 is the (R)-enantiomer of CSN5i-3. CSN5i-3 is a potent, selective and orally available inhibitor of CSN5.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2863607-74-1
  • Formula Weight
    505.56
  • Molecular Formula
    C28H29F2N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O[C@H]1[C@@H](C2=C(C=C(NC(=O)C=3N(C(C)C)N=C(C(F)F)C3)C=C2)C4=CC=CC=C4)N5C(=CN=C5)CCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Schlierf A, et al. Targeted inhibition of the COP9 signalosome for treatment of cancer. Nat Commun. 2016 Oct 24;7:13166.?
molnova catalog
related products
  • Catechin 7-O-beta-D-...

    Catechin 7-O-beta-D-glucopyranoside has intestinal anti-inflammatory activity.

  • CAY10602

    CAY10602 is a SIRT1 activator. CAY10602 was derived from high throughput screening for compounds that increase SIRT1-mediated deacetylation of a SIRT1-specific substrate.

  • DAMGO TFA

    Potent, selective agonist of Mu-opioid receptor. Antinociceptive. Stimulates calcium-activated adenylyl cyclases related cAMP production.